Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-20

Clinical Trial Update: Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults [NA]

View source ↗

Summary

A clinical trial evaluating dexmedetomidine nasal spray for treating panic attacks in adults has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine nasal spray (dexmedetomidine)

Snippet

Sponsor: Tongji University | Conditions: Dexmedetomidine | NA | Status: WITHDRAWN